FDA Inspection 1015118 — Boston Medical Center And Boston University Medical Campus IRB
The FDA completed an inspection of Boston Medical Center And Boston University Medical Campus IRB on Jun 8, 2017 in Boston, MA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 8, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Boston, MA (United States)
Additional details
IRB